Latest Breaking News On - Seamus fernandez - Page 17 : comparemela.com

AstraZeneca shares fall over 4% after lung cancer drug trial data

AstraZeneca shares fall over 4% after lung cancer drug trial data
bostonstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bostonstar.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofStephen barkerSeamus fernandezEuropean society for medical oncologyEuropean societyMedical oncologyGuggeinheim securitiesEmily field

Analysts raising forecasts for blockbuster obesity drugs

Guggenheim analyst Seamus Fernandez said the total addressable market for GLP-1 drugs like Ozempic and Wegovy could balloon to $150 billion to $200 billion.

United statesCanaccord genuityEli lilly mounjaroWilliam plovanicEli lillyIqvia brandimpactOzempic wegovyMorgan stanley flynnSeamus fernandezDrug administrationMorgan stanleyNovo nordiskCenters for diseaseAmerican heart associationWall streetTerence flynn

How much is a good night s sleep worth? A lot to these stocks

From mattresses to medical devices, these stocks are betting on Americans taking a deeper interest in their sleep.

United statesAnna pioneMichael farrellTempur sealyEli lillyGuggenheim fernandezSeth bashamStefano natellaSeamus fernandezCenters for diseaseAmerican medical associationTempur sealy internationalNational sleep foundation health indexInternational sleep products associationAlbion financial groupNovo nordisk

Altimmune, Inc (NASDAQ:ALT) Q2 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to the Altimmune, Inc. Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

United statesScot robertsJon wollebenSeamus fernandezScott harrisLouis aronneYasmeen rahimiPatrick trucchioCorinne jenkinsBoehringer ingelheim zealandVipin gargStephen harrisonLouis susserPiper sandlerMayank mamtaniOxford university

Arcutis Biotherapeutics, Inc (NASDAQ:ARQT) Q2 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Arcutis Biotherapeutics Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.

Tyler van burenRohit bhasinFrank watanabeLouise chenSeamus fernandezEric mcintyreSeb dermGoldman sachsScott burrowsSean kimVikram purohitAyisha jeterPatrick burnettArcutis biotherapeutics incLpl researchMorgan stanley